We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of 0.07% as an H1B industry with 379 employees hired as of 2025


Top In-Vitro Diagnostic Substance Manufacturing Employers



Top In-Vitro Diagnostic Substance Manufacturing Jobs

Job Title Number of Jobs Average Wage
Biostatisticians 2 $128,680
Chief Executives 2 $218,837
Sales Engineers 2 $120,682
Materials Scientists 2 $111,884
Computer Systems Analysts 1 $118,061
Financial Analysts 1 $56,077
Computer Occupations, All Other 1 $64,938
Budget Analysts 1 $73,424
Human Resources Specialists 1 $44,304
Validation Engineers 1 $100,402

Employees Over Time vs Average Salary Over Time

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where 6 employees were hired. They peaked in 2023 with 42 employees, and have since been on a decline with the most recent number of employees being 14 in 2025.
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where the average salary was $49,299. The industry peaked in 2024 with an average salary of $102,374, and has since been on a decline with the most recent average salary being $100,448 in 2025.